Hologic Sees Q4 Adj. EPS $0.97-$1.04 vs $1.04 Est., Sees FY24 Adj. EPS $4.04-$4.11 vs $4.07 Est.
Portfolio Pulse from Benzinga Newsdesk
Hologic has provided its Q4 adjusted EPS guidance in the range of $0.97 to $1.04, which is slightly below the consensus estimate of $1.04. For FY24, the company expects adjusted EPS to be between $4.04 and $4.11, aligning closely with the estimate of $4.07.
July 29, 2024 | 8:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Hologic's Q4 adjusted EPS guidance of $0.97-$1.04 is slightly below the consensus estimate of $1.04, which may cause short-term pressure on the stock. However, the FY24 adjusted EPS guidance of $4.04-$4.11 is in line with the estimate of $4.07, which could mitigate some negative sentiment.
The Q4 guidance being slightly below estimates may lead to short-term negative sentiment among investors. However, the FY24 guidance being in line with estimates could help stabilize the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100